The Walmart chain agreed to pay$ 50 million to settle the allegations following unresolved lawsuits filed on Friday, which were filed since 2020 and 2022, after the U. S. Department of Justice claimed the company had violated the Controlled Substances Act by selling thousands of invalid prescriptions and operating its pharmacies illegally.
Although Walmart's selection is neither an admission of responsibility nor an admission of guilt, a spokesman for Walmart said in a statement that the company was pleased to have resolved the issue and would continue to support the excellent work our pharmacists do every day, according to a spokesman for Walmart.
Federal prosecutors in charge of the case asserted during the trial that Walmart may have contributed to the nation's incident, where over 800, 000 people died from overdoses.
The Justice Department’s several-year investigation shows that some doctors in the chain operated as “pill factories,” prescribing large amounts of medicines at their clinics, and claiming that some pharmacists had already detected signs of overdose, early repairs of prescriptions, and medicines from illegal doctors.
“We will continue to demand accountability from companies and individuals whose illegal prescription, marketing, dispensation or distribution practices have contributed to the opioid crisis and put U.S. communities at risk,” a spokesman said.
The network has more than 4, 000 pharmacy across the nation that sell both general and specialty medications, so the justice department would have to pay him approximately$ 67, 000 for each improper prescription it makes and more than$ 15, 000 for each purchase of suspected or illegal drugs that weren't.
The agreement with Walmart may currently contain additional measures to reinforce the guidance of its pharmacies, such as evaluating suspected doctors issuing improper prescriptions, monitoring medication dispensation patterns, and setting up a phone line to report irregularities.
